Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients [5]

Journal of Clinical Psychiatry

Volumn 67, Issue 11, 2006, Pages 1820-1821

  Charuvastra, Anthony ^a   Yaeger, Deborah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE;

ADULT; ANAMNESIS; BLOOD ANALYSIS; BLOOD EXAMINATION; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; FORMICATION; HALLUCINATION; HORMONE BLOOD LEVEL; HUMAN; LETTER; MAJOR DEPRESSION; PRIORITY JOURNAL; SIDE EFFECT; SUSTAINED DRUG RELEASE; TACTILE HALLUCINATION; UNSPECIFIED SIDE EFFECT;

EID: 33845662281     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n1122e     Document Type: Letter

References (12)

1. Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med 2004;27:147-151
2. Cooper BR, Hester TJ, Maxwell RA. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 1980;215:127-134
3. Hudziak J, Rettew D. Bupropion. In: Schatzberg A, Nemeroff C, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Publishing; 2004:327-341
4. Horst WD, Preskorn SH. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 1998;51:237-254
5. Petrie EC, Veith RC, Szot P. Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:845-856
6. Zarrindast MR, Hodjati MR, Pejhan A, et al. Bupropion induces sniffing: a possible dopaminergic mechanism. Eur Neuropsychopharmacol 1996;6:299-303
7. Mitchell J, Vierkant AD. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study. J Psychol 1991;125:301-310
8. Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med 2004;27:147-151
9. Ames D, Wirshing WC, Szuba MP. Organic mental disorders associated with bupropion in three patients. J Clin Psychiatry 1992;53:53-55
10. Becker RE, Dufresne RL. Perceptual changes with bupropion, a novel antidepressant. Am J Psychiatry 1982;139:1200-1201
11. Golden RN, James SP, Sherer MA, et al. Psychoses associated with bupropion treatment. Am J Psychiatry 1985;142:1459-1462
12. Neumann M, Livak V, Paul HW, et al. Acute psychosis after administration of bupropion hydrochloride (Zyban). Pharmacopsychiatry 2002;35:247-248